<DOC>
	<DOCNO>NCT00896246</DOCNO>
	<brief_summary>This phase 1 , open-label , randomize study , design assess impact Moviprep® Klean-Prep® gastrointestinal transit . It perform two parallel group Part A two group four subject precede Part B , perform two group 12 subject . Subjects attend pre-study medical within 28 day dose post-study medical 5-10 day final dose . Within Part A Part B , subject require attend clinical unit 2 study period . Part A consisted baseline period determine individual reference time gastrointestinal transit . Part B test period gastrointestinal transit follow administration test preparation assess .</brief_summary>
	<brief_title>Scintigraphic Assessment Following Klean-Prep® Moviprep®</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male ; 2 . Aged 1865 year ; 3 . Body Mass Index 1835 kg/m2 ; 4 . Must willing able participate whole study must provide write informed consent . 1 . Participation clinical research study involve investigational drug dosage form within previous 3 month ; 2 . Subjects previously enrol study ; 3 . Subjects ever seek advice refer GP counsellor abuse misuse alcohol , non medical drug , medicinal drug substance abuse e.g . solvent ; 4 . Subjects admit current previous use Class A drug opiates , cocaine , ecstasy , LSD ( lysergic acid diethylamide ) intravenous amphetamine . Subjects admit occasional past use cannabis exclude long negative drug abuse test abstain cannabis use least 3 month ; 5 . Positive drug abuse test result ; 6 . Regular alcohol consumption &gt; 21 unit per week ( 1 Unit = ½ pint beer , 25 mL shoot 40 % spirit 125 mL glass wine ) ; 7 . Current smoker smoke within last 12 month . A breath carbon monoxide read great 10 ppm screening ; 8 . Radiation exposure clinical trial , include present study diagnostic x ray exclude background radiation , exceed 5 mSv last twelve month 10 mSv last five year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study ; 9 . Clinically significant abnormal biochemistry , haematology urinalysis judge PMI ; 10 . History gastrointestinal surgery ( exception appendectomy unless perform within previous 12 month ) ; 11 . History clinically significant cardiovascular , renal , hepatic , respiratory particularly gastrointestinal disease , especially peptic ulceration , gastrointestinal bleeding , ulcerative colitis , Crohn 's disease Irritable Bowel Syndrome ; 12 . Subjects hypersensitivity ingredient either Moviprep® Klean Prep® ; 13 . Diarrhoea constipation 7 day predict first study day . Diarrhoea define passage liquid faeces and/or stool frequency great three time per day . Constipation define failure open bowel frequently every day . 14 . Subjects exclude study consider PMI risk transmitting , blood body fluid , agent responsible AIDS ( Acquired Immunodeficiency Syndrome ) , sexually transmitted disease hepatitis . This assessed use question require potential subject decide whether fulfills category include reference card . If answer 'yes ' , subject exclude study ; 15 . Positive HBV , HCV HIV result ; 16 . Subjects receive prohibited medication describe Section 7.4 . Subjects must stop take prescribed medication purpose enter study ; 17 . Subjects history phenylketonuria glucose6phosphate dehydrogenase deficiency ; 18 . Failure satisfy PMI fitness participate reason .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>